Research article · 2012
Review articlePublished 2014
Bone Turnover and Vascular Calcification
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The impaired bone mineral metabolism followed byVascular Calcification (VC) will be presentat the beginning stage of Chronic Kidney Disease (CKD). VC can be considered as two major types, which are intimal calcification, associated with atherosclerosis, and medial calcification that involves damaged vascular smooth muscle cells (VSMCs), which leads to increase vascular stiffness and decrease vascular elasticity. Many factors control the mechanisms, and they are imbalances in serum calcium and phosphate, systemic inflammation, hyperparathyroidism, increased matrix degradation, VSMC apoptosis, decreased matrix glutamate protein, etc. These will make VSMCs Trans differentiation to phenotypic osteoblastic cells. In addition, patients with CKD usually have bone turnover problems. For a high turnover status, secondary hyperparathyroidism increases calcium and phosphate release from the bone, but for a low turnover status in a dynamic bone disorder, circulating phosphate and calcium cannot enter the bone to cause serum calcium and phosphate levels to frequently maintain at high levels. This is caused by the fact that the bone can no longer buffer the increases in phosphate and calcium load, and these conditions will cause the possibility of VC. Interestingly, the VC process will secrete sclerostin, a hormone that may act not only locally in the artery wall to reduce mineralization but also destroy bone mineralization. These problems will lead to reduced bone mass with a cycle between bone turnover and VC that only leads to problems. This article will describe the complex relationship between the rate of bone turnover and VC in CKD.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 16 Apr 2025
Crosstalk between ECs and VSMCs mediated vascular calcification in CKD by exosomal miRNA-299
Short communication · 28 Nov 2022
Vascular Calcification in Chronic Renal Disease: The Pathogenesis
Conference abstract · 23 Nov 2022
Intravenous sodium thiosulphate for vascular calcification of hemodialysis patients: A systematic review and meta-analysis
Perspective · 25 Aug 2022
Vascular Calcification in Chronic Kidney Disease: A Short Communication
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Research article · 15 Apr 2026
Anemia Management in Hemodialysis Patients in a Low-resource Setting: Blood Transfusion and Unmet Blood Needs in Burkina Faso
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Pei-Chen Wu”
- BylineArticles whose byline prints “Cai-Mei Zheng”
- BylineArticles whose byline prints “Min-Tser Liao”
- BylineArticles whose byline prints “Chia-Chao Wu”
- BylineArticles whose byline prints “Kuo-Cheng Lu”
- BylineArticles whose byline prints “Wen-Chih Liu”

